Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: the PLATON Trial

NCT03405376 is registered in ClinicalTrials.gov with Yeungnam University College of Medicine as lead sponsor.

NCT NCT03405376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: the PLATON Trial
Lead sponsor
Yeungnam University College of Medicine
Phase
Phase 4
Overall status
Unknown status
Start date
January 25, 2018
Completion date
September 30, 2020
Enrollment
49 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

branch retinal vein occlusion with macular edema